Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2023-06-13 00:00:00 ET · period of report 2023-06-11 · accession 0000921895-23-001485 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | 2023-06-11 | HBIO | Green James W | CEO, Dir | F - Tax | $5.46 | -48.4K | 2.84M | -2% | -$264.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-11 | F | D | 48,373 | $5.46 | 2,837,679 | D | — | — | (F1) The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on June 11, 2023. (F2) Includes (a) 353,140 restricted stock units that will vest in three equal installments on December 29, 2023, 2024 and 2025, (b) 104,691 restricted stock units that will vest in two equal installments on December 29, 2023 and 2024, (c) 64,899 restricted stock units that will vest on December 29, 2023, (d) 54,535 restricted stock units that will vest on December 29, 2023, (e) 671,649 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (f) 1,588,765 shares of common stock beneficially owned by the Reporting Person. |